Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This reflects a site version update and does not modify study content.
    Difference
    0.1%
    Check dated 2026-03-12T21:27:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Fallopian Tube Cancer was added to the conditions list and a new Resources section with the Genetic and Rare Diseases Information Center was added. The page footer now shows Revision: v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T01:20:13.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a revision update from v3.4.0 to v3.4.1 with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:34:29.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Glossary display was added, and metadata related to QC updates was added (Last Update Submitted that Met QC Criteria) along with Revision: v3.4.0. The older QC label variant, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T20:06:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing Revision: v3.3.3, which is a minor metadata update that does not affect trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:05:30.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2. These are administrative changes unrelated to the clinical trial details.
    Difference
    0.1%
    Check dated 2025-12-23T21:36:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.